Abbott Laboratories Com Stk NPV (NYSE:ABT)

CAPS Rating: 5 out of 5

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.


Player Avatar Loerke (92.09) Submitted: 5/1/2012 9:50:20 AM : Outperform Start Price: $20.85 ABT Score: +62.13

Abbott's charts points to one of the safest investments in the market, or at least as safe as a pharma company can get. Earnings announcements always slightly outperform the estimates. Regular dividends. This has been in my IRA for years, and I can probably retire with it.

Featured Broker Partners